Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

You can:

GPCR

NameSomatostatin receptor type 1
SpeciesHomo sapiens (Human)
GeneSSTR1
SynonymSRIF-2
SS-1-R
SS1-R
SS1R
SST1 receptor
DiseaseAlzheimer disease
Cushing's disease
Neuroendocrine cancer
Length391
Amino acid sequenceMFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
UniProtP30872
Protein Data BankN/A
GPCR-HGmod modelP30872
3D structure modelThis predicted structure model is from GPCR-EXP P30872.
BioLiPN/A
Therapeutic Target DatabaseT16633
ChEMBLCHEMBL1917
IUPHAR355
DrugBankBE0000452

Ligand

NameCHEMBL387005
Molecular formulaC73H99IN16O15S2
IUPAC name(1R,4R,7R,10S,15R,18S,21S,24S,27R,30S,33S)-10-amino-7-(4-aminobutyl)-4-benzyl-27-[(1R)-1-hydroxyethyl]-24-[(4-hydroxy-2-iodophenyl)methyl]-18-(hydroxymethyl)-33-(1H-indol-3-ylmethyl)-31-methyl-3,6,9,17,20,23,26,29,32,35,38-undecaoxo-30-[[4-[(propan-2-ylamino)methyl]phenyl]methyl]-12,13-dithia-2,5,8,16,19,22,25,28,31,34,39-undecazabicyclo[19.14.8]tritetracontane-15-carboxamide
Molecular weight1631.72
Hydrogen bond acceptor20
Hydrogen bond donor18
XlogP1.9
SynonymsBDBM50159438
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,(NMe)IAmp9,m-I-Tyr11,Lys12]SRIF
Inchi KeyBISKEDCOTSGVNU-FSWRRGMRSA-N
Inchi IDInChI=1S/C73H99IN16O15S2/c1-40(2)79-35-44-22-20-43(21-23-44)31-60-71(103)89-62(41(3)92)72(104)85-56(32-45-24-25-47(93)34-49(45)74)69(101)82-53-19-11-13-29-78-61(94)27-26-54(67(99)86-57(73(105)90(60)4)33-46-36-80-51-17-9-8-16-48(46)51)83-68(100)55(30-42-14-6-5-7-15-42)84-65(97)52(18-10-12-28-75)81-64(96)50(76)38-106-107-39-59(63(77)95)88-70(102)58(37-91)87-66(53)98/h5-9,14-17,20-25,34,36,40-41,50,52-60,62,79-80,91-93H,10-13,18-19,26-33,35,37-39,75-76H2,1-4H3,(H2,77,95)(H,78,94)(H,81,96)(H,82,101)(H,83,100)(H,84,97)(H,85,104)(H,86,99)(H,87,98)(H,88,102)(H,89,103)/t41-,50-,52-,53+,54-,55-,56+,57+,58+,59+,60+,62-/m1/s1
PubChem CID44388027
ChEMBLCHEMBL387005
IUPHARN/A
BindingDB50159438
DrugBankN/A

Structure

SDF download

2D structure
Lipinski's druglikenessThis ligand has more than 5 hydrogen bond donor.
This ligand has more than 10 hydrogen bond acceptor.
This ligand is heavier than 500 daltons.

Experimental Data

ParameterValueReferenceDatabase source
IC5014.0 nMPMID15658865BindingDB,ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417